Simplex Trading’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $264K | Sell |
58,600
-40,800
| -41% | -$178K | ﹤0.01% | 3965 |
|
|
2025
Q4 | $478K | Buy |
99,400
+15,500
| +18% | +$69.7K | ﹤0.01% | 3348 |
|
|
2025
Q3 | $380K | Buy |
83,900
+70,300
| +517% | +$258K | ﹤0.01% | 4165 |
|
|
2025
Q2 | $42K | Buy |
13,600
+5,900
| +77% | +$19.6K | ﹤0.01% | 6089 |
|
|
2025
Q1 | $26K | Sell |
7,700
-42,100
| -85% | -$140K | ﹤0.01% | 6348 |
|
|
2024
Q4 | $162K | Buy |
49,800
+26,000
| +109% | +$95.6K | ﹤0.01% | 4719 |
|
|
2024
Q3 | $91K | Buy |
23,800
+7,400
| +45% | +$28.4K | ﹤0.01% | 5321 |
|
|
2024
Q2 | $50K | Sell |
16,400
-17,400
| -51% | -$52.2K | ﹤0.01% | 6079 |
|
|
2024
Q1 | $87K | Sell |
33,800
-51,800
| -61% | -$134K | ﹤0.01% | 5728 |
|
|
2023
Q4 | $214K | Sell |
85,600
-3,900
| -4% | -$7.64K | ﹤0.01% | 4612 |
|
|
2023
Q3 | $181K | Sell |
89,500
-31,700
| -26% | -$66.5K | ﹤0.01% | 4448 |
|
|
2023
Q2 | $278K | Sell |
121,200
-75,700
| -38% | -$197K | ﹤0.01% | 3936 |
|
|
2023
Q1 | $596K | Buy |
196,900
+125,100
| +174% | +$353K | ﹤0.01% | 3092 |
|
|
2022
Q4 | $167K | Sell |
71,800
-11,400
| -14% | -$27.3K | ﹤0.01% | 4449 |
|
|
2022
Q3 | $158K | Sell |
83,200
-64,500
| -44% | -$152K | ﹤0.01% | 4927 |
|
|
2022
Q2 | $400K | Sell |
147,700
-54,000
| -27% | -$138K | ﹤0.01% | 3729 |
|
|
2022
Q1 | $601K | Sell |
201,700
-12,400
| -6% | -$38K | ﹤0.01% | 3595 |
|
|
2021
Q4 | $832K | Buy |
214,100
+180,200
| +532% | +$700K | ﹤0.01% | 3115 |
|
|
2021
Q3 | $106K | Sell |
33,900
-2,000
| -6% | -$6.67K | ﹤0.01% | 6531 |
|
|
2021
Q2 | $108K | Buy |
+35,900
| New | +$111K | ﹤0.01% | 6615 |
|
|
2021
Q1 | – | Sell |
-672
| Closed | -$238K | – | 8632 |
|
|
2020
Q4 | $238K | Sell |
672
-401
| -37% | -$1.4K | ﹤0.01% | 4375 |
|
|
2020
Q3 | $335K | Sell |
1,073
-1,233
| -53% | -$3.75K | ﹤0.01% | 3477 |
|
|
2020
Q2 | $419K | Sell |
2,306
-38
| -2% | -$62 | ﹤0.01% | 3132 |
|
|
2020
Q1 | $236K | Buy |
+2,344
| New | +$6.34K | ﹤0.01% | 3401 |
|
|
2019
Q2 | – | Sell |
-14
| Closed | -$5K | – | 6991 |
|
|
2019
Q1 | $5K | Sell |
14
-93
| -87% | -$357 | ﹤0.01% | 6451 |
|
|
2018
Q4 | $40K | Buy |
107
+44
| +70% | +$217 | ﹤0.01% | 4739 |
|
|
2018
Q3 | $59K | Buy |
63
+6
| +11% | +$60 | ﹤0.01% | 5000 |
|
|
2018
Q2 | $41K | Hold |
57
| – | – | ﹤0.01% | 5255 |
|
|
2018
Q1 | $1K | Buy |
57
+41
| +256% | +$217 | ﹤0.01% | 5508 |
|
|
2017
Q4 | $1K | Sell |
16
-24
| -60% | -$141 | ﹤0.01% | 5397 |
|
|
2017
Q3 | $6K | Buy |
+40
| New | +$171 | ﹤0.01% | 4184 |
|
|
2015
Q3 | – | Sell |
-107
| Closed | -$1K | – | 5416 |
|
|
2015
Q2 | $1K | Buy |
107
+80
| +296% | +$1.22K | ﹤0.01% | 4534 |
|
|
2015
Q1 | $9K | Sell |
27
-209
| -89% | -$4.28K | ﹤0.01% | 2997 |
|
|
2014
Q4 | $34K | Buy |
+236
| New | +$4.07K | ﹤0.01% | 1639 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM
Simplex Trading's ABUS Position: Q1 2026 in Review
Simplex Trading reduced its Arbutus Biopharma (ABUS) stake by 30% in Q1 2026, selling an estimated $29K and leaving 15,574 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5494.
Simplex Trading first reported a position in ABUS in Q1 2015 and has held it in 39 quarters since. The position peaked at $785K in Q4 2021. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.
- Simplex Trading held 15,574 shares of Arbutus Biopharma worth $70.1K as of Q1 2026.
- Simplex Trading sold 6,629 Arbutus Biopharma shares in Q1 2026, an estimated $29K.
- Arbutus Biopharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5494 holding.
- Simplex Trading first reported a position in Arbutus Biopharma in Q1 2015 and has held it in 39 quarters since.
- Simplex Trading's Arbutus Biopharma position peaked at $785K in Q4 2021.
- 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.